◼ Archived
Business
Gilead’s IBD drug eliminated symptoms for patients, mid-stage study finds
Gilead's oral drug succeeds in mid-stage ulcerative colitis trials, posting strong remission rates.
4 trends tracked about this subject — the full history, oldest to newest below.
Gilead's oral drug succeeds in mid-stage ulcerative colitis trials, posting strong remission rates.
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
13 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.